4129 Understanding Treatment Preferences for Hodgkin Lymphoma (HL) among Physicians, Patients and Caregivers
OBJECTIVES/GOALS: Although their 5-year survival >90%, young patients with HL face tradeoffs between near-term disease control and risk of treatment-related adverse effects decades later, so we seek to understand what patients and clinicians value in HL treatment decisions. METHODS/STUDY POPULATI...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2020-06-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866120004446/type/journal_article |